3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
15
Triple Negative Breast Neoplasms
12
Lung Neoplasms
12
Neoplasm Metastasis
11
Ovarian Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Fallopian Tube Neoplasms
7
Endometrial Neoplasms
7
Esophageal Neoplasms
5
Oropharyngeal Neoplasms
4
Neoplasms
4
Melanoma
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Stomach Neoplasms
2
Inflammatory Breast Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Brenner Tumor
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Interventions
Nivolumab
2
trametinib
1
selpercatinib
1
lenvatinib
1
fludarabine
1
dabrafenib
1
cemiplimab
1
aldesleukin
1
Radiotherapy, Intensity-Modulated
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Taxes
×
90 days
×
Clear all
No trials found.